About us
Strategic consulting and international investor and media relations.
We aim to level the playing field for European companies:
Cohesion amplifies impact.
Offices
- FRANKFURT
- GENÈVE
- KØBENHAVN
- LONDON
- LUXEMBOURG
- MILANO
- NEW YORK
- PARIS
- TEL AVIV
- ZÜRICH
insights
Provincialism is holding back Europe’s biotech sector
clients
Crossject is awarded a 6.9 million euros financing from the French Government, as part of the France 2030 innovation plan, to accelerate the development of ZENEO® Epinephrine
insights
What’s in store in 2024?
insights
Biotech investment: is the oncology focus coming at the expense of areas with greater need?
insights
We must reframe the discussion on Alzheimer’s disease
insights
Why are European companies shy of IPOs?
clients
AC Immune And Takeda Sign Exclusive Option And License Agreement For Active Immunotherapy Targeting Amyloid Beta For Alzheimer’s Disease
Contact us
Mission
To level the playing field for European companies by increasing their engagement with the investment community across Europe and the U.S.
More →
What sets us apart
We are pan-European and trans-Atlantic with deep expertise in strategic advice, investor relations, media relations and business development. Our passion for accelerating growth drives our commitment to help our clients achieve success.
More →
Values
Our core values include integrity, accountability, transparent communication, and a commitment to delivering high-quality work with speed. We prioritize agility, adaptability, and timeliness to drive maximum impact for our clients.
More →
Get to know us and see how our expertise can support your business